Unknown

Dataset Information

0

Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix.


ABSTRACT: In the present study, we select the Sylysia 350 (Sylysia) as mesoporous material, distearoylphosphatidylethanolamine-poly(ethylene glycol)2000 (DSPE-PEG) as absorption enhancer and hydroxy propyl methyl cellulose (HPMC) as crystallization inhibitor to prepare sorafenib tosylate (SFN) nanomitrix (MSNM@SFN) for improving the anti-tumor activity of SFN. The MSNM@SFN was prepared by solvent evaporation method. The solubility, dissolution, and bioavailability of SFN in MSNM@SFN were also investigated. The anti-tumor activity of MSNM@SFN was evaluated in vitro and in vivo. Our results indicated that the solubility and dissolution of SFN in MSNM@SFN were significantly increased. The oral bioavailability of SFN in MSNM@SFN was greatly improved 7.7-fold compared with that in SFN suspension. The enhanced anti-tumor activity of MSNM@SFN was confirmed in vitro and in vivo experiments. This nanomatrix developed in this study could be a promising drug delivery platform for improving the therapeutic efficacy of poorly water-soluble drugs.

SUBMITTER: Guo Y 

PROVIDER: S-EPMC8241045 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4679361 | biostudies-literature
| S-EPMC5253252 | biostudies-literature
| S-EPMC3482233 | biostudies-literature
| S-EPMC2923475 | biostudies-literature
| S-EPMC6467716 | biostudies-literature
| S-EPMC8002161 | biostudies-literature
| S-EPMC6110745 | biostudies-literature
| S-EPMC3197750 | biostudies-literature
| S-EPMC4652792 | biostudies-literature
2022-09-01 | GSE197944 | GEO